Delivery Order SPE2DB24D2100-SPE2DB25FBFPD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $93,147.08 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packages) on July 30, 2025. This firm fixed-price, non-set-aside contract will be performed at the company's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of July 31, 2025. The award represents a single delivery order execution under AmerisourceBergen's broader pharmaceutical supply relationship with the...
- The Defense Logistics Agency awarded a $23,545.12 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count units). This is a firm fixed-price, non-set-aside contract with performance completion targeted for July 28, 2025, and fulfillment from the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $2,999.35 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packaging) on July 24, 2025, with completion scheduled for July 25, 2025. This non-set-aside, firm fixed-price delivery order represents a pharmaceutical supply transaction supporting federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills the order from its...
- The Defense Logistics Agency awarded a $24,953.82 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on July 22, 2025, with completion scheduled for July 23, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs across military and...
- The Defense Logistics Agency awarded a delivery order valued at $23,544.32 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packages) under a firm fixed-price contract. The award was issued on July 30, 2025, with an ultimate completion date of July 31, 2025, and no set-aside designation was utilized. Performance will take place at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a small-value transaction within...
- The Defense Logistics Agency awarded a $13,858.91 firm fixed price delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) with an ultimate completion date of July 28, 2025. This non-set-aside award was competitively awarded and represents a child order under AmerisourceBergen's larger pharmaceutical supply contract vehicle. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $27,371.81 to supply NURTEC ODT 75 mg tablets (8-count units) under a firm fixed price contract. The order, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a non-competitive, non-set-aside procurement fulfilled through AmerisourceBergen's existing contract vehicle. Performance will occur at the vendor's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $89,299.27 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count units) on July 18, 2025, with an ultimate completion date of July 21, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a $15,976.54 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packages). The contract, which is non-set-aside and competitively awarded, carries a firm fixed price and is scheduled for completion by July 21, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $49,744.77 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count packaging) on July 24, 2025, with completion scheduled for July 25, 2025. This firm fixed-price delivery order carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its Corporate Office location in...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBFPDDelivery Order
The Defense Logistics Agency awarded a $63,097.82 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of NURTEC ODT 75 MG tablets (quantity: 8 units). This firm fixed-price delivery order, which is not set-aside, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 1, 2025. The award represents a single transaction under AmerisourceBergen's broader federal pharmaceutical supply portfolio. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor serving federal military and healthcare systems, AmerisourceBergen supplies a comprehensive range of medications and medical commodities through competitively awarded contracts. NURTEC ODT is a migraine treatment medication, reflecting the company's role in providing specialized pharmaceutical products to support Defense Health Agency and other federal healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $63.1k | 7/31/25 |